Roche: Some Companies Rebuild, This One Reloads

27-12-2013 DailyFinanceComments (0)


In recent months, Roche has signed on with Polyphor (antibiotics) and Prothena (Parkinson's), and build up its oncology pipeline with Molecular Partners (DARPins) and immatics (TUMAPs). I feel the later two are significant, as it builds on some already ...

Read more on DailyFinance

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top